Correction to: miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.

This erratum addresses corrections to the article titled 'miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1' published in Journal of physiology and biochemistry on 13 July 2018. In the original article, the transwell microscope images presented in Fig. 4C of the Hca-P mimic group and Fig. 5E of Hca-P PF group were accidentally misused during the assembly of the figures. These errors have now been corrected and does not change the conclusions of the study. The authors apologize for this oversight and any confusion it may have caused.